GSK PLC (GLAXF)
16.83
-0.21
(-1.24%)
USD |
OTCM |
Dec 13, 16:00
GSK Market Cap: 68.68B for Dec. 13, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 148.44M |
| Biodexa Pharmaceuticals PLC | 2.439M |
| Verona Pharma PLC | 3.389B |
| NuCana PLC | 4.985M |
| Autolus Therapeutics PLC | 662.64M |
Market Cap Related Metrics
| PE Ratio | 21.88 |
| PS Ratio | 1.748 |
| Price to Book Value | 3.664 |
| Price to Free Cash Flow | 11.47 |
| Price | 16.83 |
| Earnings Yield | 4.57% |
| Operating PE Ratio | 12.24 |
| Normalized PE Ratio | 18.67 |